“Acquired CD20 Loss As a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma ”. Mediterranean Journal of Hematology and Infectious Diseases 18, no. 1 (January 1, 2026): e2026014. Accessed June 9, 2026. https://www.mjhid.org/mjhid/article/view/6199.